Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Public ClinicalTrials.gov record NCT05496296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Controlled, Open-Label, Parallel Group, Multi-Center, Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pressure injuries, commonly known as pressure ulcers, affect over 2.5 million people in the United States. Pressure injuries are classified into four escalating stages, from intact skin to full thickness wounds with deep tissue loss and exposed bone. This study will compare current standard of care treatment (as recommended by the National Pressure Injury Advisory Panel) to treatment with Altrazeal® in patients with stage 2, stage 3 and stage 4 pressure injury wounds. Altrazeal® is a Class 1, 501(k) exempt medical device listed with the FDA as a "dressing, wound, hydrogel" and has an extended wear time of up to 30 days. Subjects can be enrolled in the study either as an outpatient, or while hospitalized. Half of the subjects will be randomized to standard of care treatment, and the other half will be randomized to Altrazeal®. There are a total of up to 12 study visits taking place over 12 weeks.
Study identification
- NCT ID
- NCT05496296
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 300 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2023
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Nov 19, 2025
2023 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Diego VA | San Diego | California | 92161 | Recruiting |
| Medstar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | Recruiting |
| MedStar National Rehabilitation Hospital | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Northwestern Medicine | Chicago | Illinois | 60611 | Active, not recruiting |
| Medstar Franklin Square Medical Center | Baltimore | Maryland | 21237 | Recruiting |
| Medstar Good Samaritan Hospital | Baltimore | Maryland | 21239 | Recruiting |
| Rutgers New Jersey Medical School, Ambulatory Care Center-Wound Care Clinic | Newark | New Jersey | 07103 | Recruiting |
| Northwell Health System/Zucker School of Medicine | Lake Success | New York | 11042 | Recruiting |
| NYU Langone Hospital-Long Island | Mineola | New York | 11501 | Recruiting |
| James J. Peters VA Medical Center | The Bronx | New York | 10468 | Recruiting |
| Westchester Medical Center, 100 Woods, Road, Taylor Care Pavillion | Valhalla | New York | 10595 | Recruiting |
| University of Pittsburgh Medical Center (UPMC) Presbyterian | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| VA North Texas Healthcare System | Dallas | Texas | 75243 | Recruiting |
| Michael E. DeBakey Houston VAMC | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05496296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05496296 live on ClinicalTrials.gov.